Wedbush Raises Price Target on Medtronic (MDT) to $82 Following 4Q Report

Leerink Partners Raises Price Target on Medtronic (MDT) Following 4Q Report

Leerink Partners reiterated a Market Perform rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $85.00 (from $82.00), following the company's 4Q earnings report. MDT delivered its 6th consecutive quarter of mid- to high-single-digit sales growth, building a consistent track record.

Analyst Danielle Antalffy commented, "MDT shares traded lower yesterday driven by what we believe were expectations of more positive operating leverage than the company delivered, potentially as well as a more... More

BTIG Downgrades Medtronic, Inc. (MDT) to Neutral

BTIG downgraded Medtronic, Inc. (NYSE: MDT) from Buy to Neutral. Analyst Sean Lavin sees valuation as full and he noted disappointing margins.

"Foremost, at ~$80 we feel valuation is full and no longer see 15% upside over the next 12 months. We also feel... More

Medtronic (MDT): In-Line Quarter, Raising PT - Piper Jaffray

Piper Jaffray analyst, Brooks West, raised his PT on Medtronic (NYSE: MDT) to $93 from $85 after the company reported F4Q revenue of $7.57B (+6%cc) vs. consensus of $7.49B. EPS of $1.27, was $0.01 above consensus but the Streets expectation for 300bp of sequential operating leverage... More

Medtronic (MDT) Tops Q4 EPS by 1c

Medtronic (NYSE: MDT) reported Q4 EPS of $1.27, $0.01 better than the analyst estimate of $1.26. Revenue for the quarter came in at $7.57 billion versus the consensus estimate of $7.49 billion.

GUIDANCE:

Medtronic sees FY2017 EPS of $4.60-$4.70, versus the consensus of $4.70.

In fiscal... More

Stocks with Implied Volatility Movement

Rite Aid (NYSE: RAD) 27, Medtronic (NYSE: MDT) 18 implied volatility is above its IV index mean

Dollar Tree (NASDAQ: DLTR) 24, Applied Materials (NASDAQ: AMAT) 24 implied... More